Laubach, Jacob
204  results:
Search for persons X
?
5

P-277 Venetoclax versus bortezomib, in combination with dar..:

Kaufman, Jonathan ; Quach, Hang ; Baz, Rachid...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S188-S189 , 2023
 
?
 
?
 
?
8

P-164 Reduction in disease symptoms/impacts after daratumum..:

Silbermann, Rebecca ; Laubach, Jacob ; Kaufman, Jonathan...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S125-S126 , 2023
 
?
9

Multivariable Analyses of Prognostic Factors for Progressio..:

Hassoun, Hani ; Jacobus, Susanna J ; Richardson, Paul G....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S396-S397 , 2023
 
?
10

Clinical Outcomes of Monoclonal Gammopathy of Renal Signifi..:

Terashita, Maho ; Selamet, Umut ; Midha, Shonali...
Kidney International Reports.  8 (2023)  12 - p. 2765-2777 , 2023
 
?
11

P-016 Disparities in access and practice patterns of BCMA-d..:

Hassan, Hamza ; Samur, Mehmet ; Cohen, Adam...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S41-S42 , 2023
 
?
12

P-099 Phase II trial of daratumumab, bortezomib, lenalidomi..:

Nadeem, Omar ; Redd, Robert ; Mo, Clifton...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S89 , 2023
 
?
13

Stem Cell Mobilization Yields with Daratumumab- and Lenalid..:

Chhabra, Saurabh ; Callander, Natalie ; Watts, Nicole L....
Transplantation and Cellular Therapy.  29 (2023)  3 - p. 174.e1-174.e10 , 2023
 
?
14

P-036 Real world single center expeirence of long-term toxi..:

Costello, Patrick ; Laubach, Jacob ; Mo, Clifton...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S54 , 2023
 
1-15